BioPathwise 2.0, Map Viewer, CLC Free Workbench 3.0, SimTK Simbody, SimTK ISIM, ToRNADo, CERF-Notebook, Jmol, International Protein Index, Unleashed Global Services, Experion 2.0 | GenomeWeb

The BioAnalytics Group has released BioPathwise 2.0, a new version of its pathway-centric software and database system. The software includes a reaction repository and interface tools that allow users to pull in peer-reviewed information about specific reactions. Biologists can use the software to draw pathways and conduct virtual experiments, computational biologists and statisticians can view mathematical formulas that represent the processes at work, and programmers have access to tools that will enable them to integrate legacy data and third-party software packages.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.